Tulchinsky TH, Varavikova EA, Cohen MJ
The primary appeal of these medications lies in their ability to promote significant weight loss, making them attractive options for individuals struggling with obesity
Explicit marketing towards GLP-1 users may therefore be a mistake, as that risks turning off others who are also looking for products that are nutrient dense, high protein, etc, but who may think the product being marketed is not for them
doi: 10.1038/s41598-019-38956-2 94 WickiAWildDStorchDSeemayerCGotthardtMBeheMet al
It is strongly associated with the development and progression of hepatic steatosis, increased oxidative stress, mitochondrial dysfunction, activation of pro-inflammatory and pro-fibrotic pathways, and systemic metabolic dysregulation
Khedr NF